Too Good to Be True
- PMID: 32459416
- DOI: 10.1097/AOG.0000000000003916
Too Good to Be True
Comment on
-
Ovarian Cancer After Prophylactic Salpingectomy in a Patient With Germline BRCA1 Mutation.Obstet Gynecol. 2020 Jun;135(6):1270-1274. doi: 10.1097/AOG.0000000000003864. Obstet Gynecol. 2020. PMID: 32459417 Free PMC article. Review.
References
-
- Lu KH, Cun HT. Unanswered questions in high-risk women undergoing risk-reducing salpingo-oophorectomy. Obstet Gynecol 2020;135:495–7.
-
- Hereditary breast and ovarian cancer syndrome. Practice Bulletin No. 182. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;130:e110–26.
-
- Doren A, Vecchiola A, Aguirre B, Villaseca P. Gynecological-endocrinological aspects in women carriers of BRCA1/2 gene mutations. Climacteric 2018;21:529–35.
-
- Nebgen DR, Hurteau J, Holman LL, Bradford A, Munsell MF, Soletsky BR, et al. Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: a pilot study in women with BRCA1/2 mutations. Gynecol Oncol 2018;150:79–84.
-
- Leblanc E, Narducci F, Farre I, Peyrat JP, Taieb S, Adenis C, et al. Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development. Gynecol Oncol 2011;121:472–6.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
